Europe's National Medical Technology Innovation Centres will advance R&D
This article was originally published in Clinica
The European medtech association, Eucomed, is hoping its members will soon profit from the European Commission's pledge to support initiatives targeted at promoting innovative products, a policy enshrined in the Lisbon agenda, writes Amanda Maxwell. Speaking to Clinica in an interview at Eucomed's Brussels headquarters last week, Eucomed director general Maurice Wagner said that his association is on the point of launching a new initiative to set up National Medical Technology Innovation Centres (NMTICs) in as many Eucomed national association countries as feasible.
You may also be interested in...
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.